List of Tables
Table 1. Global Octreotide Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Octreotide Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Octreotide Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Octreotide Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Octreotide Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Octreotide Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Octreotide Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Octreotide Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Octreotide Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Octreotide Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Octreotide Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Octreotide Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Octreotide Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Octreotide Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Octreotide Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Octreotide Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Octreotide Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Octreotide Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Octreotide Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Octreotide Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Octreotide Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Octreotide Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Octreotide Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Octreotide Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Octreotide Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Octreotide Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Octreotide Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Octreotide Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Octreotide Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Octreotide Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Octreotide Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Octreotide Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Octreotide Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Octreotide Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Octreotide Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Octreotide Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Octreotide Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Octreotide Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Octreotide Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Octreotide Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Octreotide Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Octreotide Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Octreotide Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Octreotide Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Octreotide Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Octreotide Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Octreotide Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Octreotide Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Octreotide Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Octreotide Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Octreotide Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Octreotide Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Octreotide Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Octreotide Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Octreotide Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Octreotide Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Octreotide Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Octreotide Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Octreotide Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Octreotide Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Octreotide Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Octreotide Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Octreotide Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Octreotide Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Octreotide Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Octreotide Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Octreotide Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Octreotide Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novartis Octreotide Drugs Product
Table 74. Novartis Recent Developments/Updates
Table 75. Sun Pharmaceutical Company Information
Table 76. Sun Pharmaceutical Description and Business Overview
Table 77. Sun Pharmaceutical Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Sun Pharmaceutical Octreotide Drugs Product
Table 79. Sun Pharmaceutical Recent Developments/Updates
Table 80. Teva Company Information
Table 81. Teva Description and Business Overview
Table 82. Teva Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Teva Octreotide Drugs Product
Table 84. Teva Recent Developments/Updates
Table 85. Gland Pharma Company Information
Table 86. Gland Pharma Description and Business Overview
Table 87. Gland Pharma Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Gland Pharma Octreotide Drugs Product
Table 89. Gland Pharma Recent Developments/Updates
Table 90. Chiesi Farmaceutici S.p.A Company Information
Table 91. Chiesi Farmaceutici S.p.A Description and Business Overview
Table 92. Chiesi Farmaceutici S.p.A Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Chiesi Farmaceutici S.p.A Octreotide Drugs Product
Table 94. Chiesi Farmaceutici S.p.A Recent Developments/Updates
Table 95. Fresenius Kabi Company Information
Table 96. Fresenius Kabi Description and Business Overview
Table 97. Fresenius Kabi Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Fresenius Kabi Octreotide Drugs Product
Table 99. Fresenius Kabi Recent Developments/Updates
Table 100. Mylan Company Information
Table 101. Mylan Description and Business Overview
Table 102. Mylan Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Mylan Octreotide Drugs Product
Table 104. Mylan Recent Developments/Updates
Table 105. Sagent Pharmaceuticals Company Information
Table 106. Sagent Pharmaceuticals Description and Business Overview
Table 107. Sagent Pharmaceuticals Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Sagent Pharmaceuticals Octreotide Drugs Product
Table 109. Sagent Pharmaceuticals Recent Developments/Updates
Table 110. West-Ward Pharmaceuticals Company Information
Table 111. West-Ward Pharmaceuticals Description and Business Overview
Table 112. West-Ward Pharmaceuticals Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. West-Ward Pharmaceuticals Octreotide Drugs Product
Table 114. West-Ward Pharmaceuticals Recent Developments/Updates
Table 115. Suzhou Tianma Pharmaceutical Company Information
Table 116. Suzhou Tianma Pharmaceutical Description and Business Overview
Table 117. Suzhou Tianma Pharmaceutical Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Suzhou Tianma Pharmaceutical Octreotide Drugs Product
Table 119. Suzhou Tianma Pharmaceutical Recent Developments/Updates
Table 120. Sihuan Pharmaceutical Company Information
Table 121. Sihuan Pharmaceutical Description and Business Overview
Table 122. Sihuan Pharmaceutical Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sihuan Pharmaceutical Octreotide Drugs Product
Table 124. Sihuan Pharmaceutical Recent Developments/Updates
Table 125. Chengdu Tiantaishan pharmaceutical Company Information
Table 126. Chengdu Tiantaishan pharmaceutical Description and Business Overview
Table 127. Chengdu Tiantaishan pharmaceutical Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Chengdu Tiantaishan pharmaceutical Octreotide Drugs Product
Table 129. Chengdu Tiantaishan pharmaceutical Recent Developments/Updates
Table 130. Hybio Pharmaceutical Company Information
Table 131. Hybio Pharmaceutical Description and Business Overview
Table 132. Hybio Pharmaceutical Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Hybio Pharmaceutical Octreotide Drugs Product
Table 134. Hybio Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Octreotide Drugs Distributors List
Table 138. Octreotide Drugs Customers List
Table 139. Octreotide Drugs Market Trends
Table 140. Octreotide Drugs Market Drivers
Table 141. Octreotide Drugs Market Challenges
Table 142. Octreotide Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Octreotide Drugs
Figure 2. Global Octreotide Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Octreotide Drugs Market Share by Type: 2025 & 2032
Figure 4. Injections Product Picture
Figure 5. Oral Capsules Product Picture
Figure 6. Global Octreotide Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Octreotide Drugs Market Share by Application: 2025 & 2032
Figure 8. Neuroendocrine Tumors
Figure 9. Acromegaly
Figure 10. Other
Figure 11. Global Octreotide Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Octreotide Drugs Market Size (US$ Million), 2021–2032
Figure 13. Global Octreotide Drugs Sales (K Units), 2021–2032
Figure 14. Global Octreotide Drugs Average Price (US$/Unit), 2021–2032
Figure 15. Octreotide Drugs Report Years Considered
Figure 16. Octreotide Drugs Sales Share by Manufacturers in 2025
Figure 17. Global Octreotide Drugs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Octreotide Drugs Players: Market Share by Revenue in Octreotide Drugs in 2025
Figure 19. Octreotide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Octreotide Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Octreotide Drugs Sales Market Share by Country (2021–2032)
Figure 22. North America Octreotide Drugs Revenue Market Share by Country (2021–2032)
Figure 23. United States Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Octreotide Drugs Sales Market Share by Country (2021–2032)
Figure 26. Europe Octreotide Drugs Revenue Market Share by Country (2021–2032)
Figure 27. Germany Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Octreotide Drugs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Octreotide Drugs Revenue Market Share by Region (2021–2032)
Figure 34. China Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Octreotide Drugs Sales Market Share by Country (2021–2032)
Figure 42. Latin America Octreotide Drugs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Octreotide Drugs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Octreotide Drugs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Octreotide Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Octreotide Drugs by Type (2021–2032)
Figure 53. Global Revenue Market Share of Octreotide Drugs by Type (2021–2032)
Figure 54. Global Octreotide Drugs Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Octreotide Drugs by Application (2021–2032)
Figure 56. Global Revenue Market Share of Octreotide Drugs by Application (2021–2032)
Figure 57. Global Octreotide Drugs Price (US$/Unit) by Application (2021–2032)
Figure 58. Octreotide Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
